Change over period: —
NSE · CAMLINFINE
CAMLINFINE
-59.3% from the 52-week high · +0.0% above the low
Camlin Fine Sciences Ltd. engages in the research, development, manufacture, and marketing of fine chemicals which are used as antioxidants, industrial chemicals, and aroma products. The company is headquartered in Mumbai, Maharashtra and currently employs 478 full-time employees. The company went IPO on 2015-01-20. The firm is a provider of antioxidants and shelf-life solutions, aroma ingredients, health and wellness, and performance chemicals. Its products include BHA, TBHQ and GUAIACOL BULK. The firm offers its products across various industries, including food and beverages, animal nutrition, pet food, aquaculture, bio-fuels, pharmaceuticals, dyes and pigments, petrochemicals and polymers. The company manufactures Methyl Vanillin which is sold under the Company’s brand name VanesseTM and Ethyl Vanillin, that is used in a range of applications, such as chocolates, ice creams, bakery products, incense sticks, perfumes, soaps, personal care and cosmetic products. Its performance chemicals business is involved in providing specialty chemicals, including Guaiacol, Veratrole, TBC, MEHQ, CME, HQEE, Hydroquinone and Catechol.
The short version. CAMLINFINE reported revenue of ₹491 crore for Sep 2026, up 6.7% from a year earlier. Net profit was ₹-28 crore. Return on equity was 2.6% in Mar 2026. Promoter holding was 48.03% in Sep 2026, up 0.01 points over 8 quarters.
1 · The price
How has the stock traded?
CAMLINFINE trades 59.3% below its 52-week high and 0.0% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹491 cr.
2.6 pts lower than a year earlier.
Revenue compounded at 1.3% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 491 | 520 | 425 | 457 | 460 | 424 | 437 | 433 |
| Net profit | -28 | -32 | 88 | -36 | -14 | -10 | -1 | -4 |
| Net margin % | -5.7 | -6.1 | 20.8 | -7.9 | -3.1 | -2.4 | -0.2 | -1.0 |
| EPS (₹) | -1.45 | -1.65 | 4.59 | -1.89 | -0.77 | -0.53 | -0.04 | -0.22 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1723 | 1667 | 1613 | 1682 | 1412 | 1187 | 1049 | 892 |
| Net profit | 28 | -139 | -93 | 52 | 61 | 51 | 30 | 4 |
| Net margin % | 1.6 | -8.3 | -5.8 | 3.1 | 4.3 | 4.3 | 2.9 | 0.4 |
| EPS (₹) | 1.44 | -7.4 | -4.94 | 2.96 | 3.45 | 3.56 | 2.23 | 0.29 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 2.6% in Mar 2026; debt to equity is 0.64.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 2.6 | -15.4 | -10.7 | 6.4 |
| Return on capital % | 2.9 | 12.7 | -3.2 | 11.0 |
| EBITDA margin % | 6.3 | 12.7 | 2.4 | 11.9 |
| Net margin % | 1.6 | -8.3 | -5.7 | 3.1 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 1.3% | 8.0% |
| Profit CAGR | -19.1% | -11.5% |
4 · The owners
Who holds it, and are they adding?
Up 0.01 pts over 8 quarters.
Up 0.19 pts over 8 quarters.
Up 1.93 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 48.02 | 49.1 | 49.1 | 49.08 | 48.03 | 48.03 | 48.03 | 48.03 | +0.01 |
| FII | 0.76 | 1.47 | 2.88 | 2.12 | 2.12 | 0.94 | 0.91 | 0.95 | +0.19 |
| DII | 3.39 | 3.83 | 4.14 | 5.48 | 7.77 | 7.7 | 5.42 | 5.32 | +1.93 |
| Public | 47.83 | 45.61 | 43.87 | 43.33 | 42.08 | 43.32 | 45.64 | 45.7 | -2.13 |
Mutual fund holdings · Oct 2026
3 schemes hold this stock
3 the month before.
- ICICI Prudential Commodities Fund1.32% of NAV
- ICICI Prudential Multi Cap Fund0.16% of NAV
- ICICI Prudential Mid Cap Fund0.01% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for CAMLINFINE are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about CAMLINFINE
What is the CAMLINFINE share price?
CAMLINFINE (CAMLINFINE) last closed at ₹71.14, down 1.4% on the day. Its 52-week range is ₹72.15 to ₹177.37.
What is the market cap of CAMLINFINE?
CAMLINFINE has a market capitalisation of about ₹2,350 crore.
How are CAMLINFINE's latest results?
CAMLINFINE reported revenue of ₹491 crore for Sep 2026, up 6.7% from a year earlier. Net profit was ₹-28 crore. Return on equity was 2.6% in Mar 2026. Promoter holding was 48.03% in Sep 2026, up 0.01 points over 8 quarters.
Who owns CAMLINFINE?
As of Sep 2026, shareholding was: Promoter 48.03%, FII 0.95%, DII 5.32%, Public 45.7%.
How many mutual funds hold CAMLINFINE?
3 mutual fund schemes held CAMLINFINE in October 2026. That compares with 3 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 08 Jan 2025 · Rights issue 5:41
- 28 Jul 2016 · Dividend - Rs. 0.45
- 27 Jul 2015 · Dividend - Rs. 0.45
- 04 Sep 2014 · Stock Split From Rs.2/- to Rs.1/-
- 24 Jul 2014 · Dividend - Rs. 0.7
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.